GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체
본 발명은 일반식 (I)을 갖는 신규 헤테로시클릭 화합물 및 이의 약제학적으로 허용되는 염을 제공하고, 여기서 변수는 본원에 기재된 바와 같다. JPEGpct00079.jpg6149(I) 상기 화합물을 포함하는 약제학적 조성물, 상기 화합물을 제조하는 공정 및 상기 화합물을 약제로서 사용하는 방법, 특히 급성 신경학적 장애, 만성 신경학적 장애 및/또는 인지 장애의 치료 또는 예방을 위해 화합물을 사용하는 방법이 또한 제공된다. The invention provides novel heterocyclic compounds having...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GALLEY GUIDO OLIVARES MORALES ANDRES MIGUEL RUNTZ SCHMITT VALERIE HERNANDEZ MARIA CLEMENCIA CECERE GIUSEPPE GOBBI LUCA KOBLET ANDREAS |
| description | 본 발명은 일반식 (I)을 갖는 신규 헤테로시클릭 화합물 및 이의 약제학적으로 허용되는 염을 제공하고, 여기서 변수는 본원에 기재된 바와 같다. JPEGpct00079.jpg6149(I) 상기 화합물을 포함하는 약제학적 조성물, 상기 화합물을 제조하는 공정 및 상기 화합물을 약제로서 사용하는 방법, 특히 급성 신경학적 장애, 만성 신경학적 장애 및/또는 인지 장애의 치료 또는 예방을 위해 화합물을 사용하는 방법이 또한 제공된다.
The invention provides novel heterocyclic compounds having the general formula (I), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240065086A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240065086A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240065086A3</originalsourceid><addsrcrecordid>eNrjZLBzd3RyVHBUcHf09XU0VAhw9H0zZ8_rhXPetMx5M3eGwtspe14vW_O6v0Xh9ZQpb6a2vFkw5-3UBoU3cxYAxd5s2sLDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-K9g4wMjEwMDMxMDSzMHI2JUwUAwF08TA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체</title><source>esp@cenet</source><creator>GALLEY GUIDO ; OLIVARES MORALES ANDRES MIGUEL ; RUNTZ SCHMITT VALERIE ; HERNANDEZ MARIA CLEMENCIA ; CECERE GIUSEPPE ; GOBBI LUCA ; KOBLET ANDREAS</creator><creatorcontrib>GALLEY GUIDO ; OLIVARES MORALES ANDRES MIGUEL ; RUNTZ SCHMITT VALERIE ; HERNANDEZ MARIA CLEMENCIA ; CECERE GIUSEPPE ; GOBBI LUCA ; KOBLET ANDREAS</creatorcontrib><description>본 발명은 일반식 (I)을 갖는 신규 헤테로시클릭 화합물 및 이의 약제학적으로 허용되는 염을 제공하고, 여기서 변수는 본원에 기재된 바와 같다. JPEGpct00079.jpg6149(I) 상기 화합물을 포함하는 약제학적 조성물, 상기 화합물을 제조하는 공정 및 상기 화합물을 약제로서 사용하는 방법, 특히 급성 신경학적 장애, 만성 신경학적 장애 및/또는 인지 장애의 치료 또는 예방을 위해 화합물을 사용하는 방법이 또한 제공된다.
The invention provides novel heterocyclic compounds having the general formula (I), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.</description><language>kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240514&DB=EPODOC&CC=KR&NR=20240065086A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240514&DB=EPODOC&CC=KR&NR=20240065086A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GALLEY GUIDO</creatorcontrib><creatorcontrib>OLIVARES MORALES ANDRES MIGUEL</creatorcontrib><creatorcontrib>RUNTZ SCHMITT VALERIE</creatorcontrib><creatorcontrib>HERNANDEZ MARIA CLEMENCIA</creatorcontrib><creatorcontrib>CECERE GIUSEPPE</creatorcontrib><creatorcontrib>GOBBI LUCA</creatorcontrib><creatorcontrib>KOBLET ANDREAS</creatorcontrib><title>GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체</title><description>본 발명은 일반식 (I)을 갖는 신규 헤테로시클릭 화합물 및 이의 약제학적으로 허용되는 염을 제공하고, 여기서 변수는 본원에 기재된 바와 같다. JPEGpct00079.jpg6149(I) 상기 화합물을 포함하는 약제학적 조성물, 상기 화합물을 제조하는 공정 및 상기 화합물을 약제로서 사용하는 방법, 특히 급성 신경학적 장애, 만성 신경학적 장애 및/또는 인지 장애의 치료 또는 예방을 위해 화합물을 사용하는 방법이 또한 제공된다.
The invention provides novel heterocyclic compounds having the general formula (I), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBzd3RyVHBUcHf09XU0VAhw9H0zZ8_rhXPetMx5M3eGwtspe14vW_O6v0Xh9ZQpb6a2vFkw5-3UBoU3cxYAxd5s2sLDwJqWmFOcyguluRmU3VxDnD10Uwvy41OLCxKTU_NSS-K9g4wMjEwMDMxMDSzMHI2JUwUAwF08TA</recordid><startdate>20240514</startdate><enddate>20240514</enddate><creator>GALLEY GUIDO</creator><creator>OLIVARES MORALES ANDRES MIGUEL</creator><creator>RUNTZ SCHMITT VALERIE</creator><creator>HERNANDEZ MARIA CLEMENCIA</creator><creator>CECERE GIUSEPPE</creator><creator>GOBBI LUCA</creator><creator>KOBLET ANDREAS</creator><scope>EVB</scope></search><sort><creationdate>20240514</creationdate><title>GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체</title><author>GALLEY GUIDO ; OLIVARES MORALES ANDRES MIGUEL ; RUNTZ SCHMITT VALERIE ; HERNANDEZ MARIA CLEMENCIA ; CECERE GIUSEPPE ; GOBBI LUCA ; KOBLET ANDREAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240065086A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GALLEY GUIDO</creatorcontrib><creatorcontrib>OLIVARES MORALES ANDRES MIGUEL</creatorcontrib><creatorcontrib>RUNTZ SCHMITT VALERIE</creatorcontrib><creatorcontrib>HERNANDEZ MARIA CLEMENCIA</creatorcontrib><creatorcontrib>CECERE GIUSEPPE</creatorcontrib><creatorcontrib>GOBBI LUCA</creatorcontrib><creatorcontrib>KOBLET ANDREAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GALLEY GUIDO</au><au>OLIVARES MORALES ANDRES MIGUEL</au><au>RUNTZ SCHMITT VALERIE</au><au>HERNANDEZ MARIA CLEMENCIA</au><au>CECERE GIUSEPPE</au><au>GOBBI LUCA</au><au>KOBLET ANDREAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체</title><date>2024-05-14</date><risdate>2024</risdate><abstract>본 발명은 일반식 (I)을 갖는 신규 헤테로시클릭 화합물 및 이의 약제학적으로 허용되는 염을 제공하고, 여기서 변수는 본원에 기재된 바와 같다. JPEGpct00079.jpg6149(I) 상기 화합물을 포함하는 약제학적 조성물, 상기 화합물을 제조하는 공정 및 상기 화합물을 약제로서 사용하는 방법, 특히 급성 신경학적 장애, 만성 신경학적 장애 및/또는 인지 장애의 치료 또는 예방을 위해 화합물을 사용하는 방법이 또한 제공된다.
The invention provides novel heterocyclic compounds having the general formula (I), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20240065086A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | GABA A GAMMA1 PAM으로서의 피리도 디아제핀 유도체 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T16%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GALLEY%20GUIDO&rft.date=2024-05-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240065086A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |